If anti-CD8α antibody was given from day 5 after BMT (a time point when the majority of the FRC network remains intact; Figure 2B), we found that FRC numbers were preserved to a similar extent as controls without GVHD when evaluated at the 4-week time point (Figure 2E). The gene discussed is CD8A; the disease is graft versus host disease.